Clinical Trial Update: The Use of a Forecasting System for Predicting Exacerbations of COPD [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 study sponsored by AstraZeneca evaluated a forecasting system to predict COPD exacerbations; the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | EARLY_Phase 1 | Status: COMPLETED